These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34502494)

  • 1. Impact of Reactive Oxygen and Nitrogen Species Produced by Plasma on Mdm2-p53 Complex.
    Attri P; Kurita H; Koga K; Shiratani M
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds.
    Sgammato R; Desiderio D; Lamberti A; Raimo G; Novellino E; Carotenuto A; Masullo M
    Electrophoresis; 2015 Dec; 36(24):3101-4. PubMed ID: 26383830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.
    Savchenko A; Yurchenko M; Snopok B; Kashuba E
    Mol Biotechnol; 2009 Mar; 41(3):270-7. PubMed ID: 18989794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
    Niu RJ; Zheng QC; Zhang JL; Zhang HX
    J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibitors of the p53-MDM2.
    Hu CQ; Hu YZ
    Curr Med Chem; 2008; 15(17):1720-30. PubMed ID: 18673221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction.
    Thayer KM; Beyer GA
    PLoS One; 2016; 11(3):e0147806. PubMed ID: 26992014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatic-aromatic interactions in the formation of the MDM2-p53 complex.
    Espinoza-Fonseca LM; García-Machorro J
    Biochem Biophys Res Commun; 2008 Jun; 370(4):547-51. PubMed ID: 18355443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors.
    Kannan S; Partridge AW; Lane DP; Verma CS
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition.
    Macchiarulo A; Giacchè N; Carotti A; Baroni M; Cruciani G; Pellicciari R
    J Chem Inf Model; 2008 Oct; 48(10):1999-2009. PubMed ID: 18826207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
    Patil SP; Pacitti MF; Gilroy KS; Ruggiero JC; Griffin JD; Butera JJ; Notarfrancesco JM; Tran S; Stoddart JW
    J Comput Aided Mol Des; 2015 Feb; 29(2):155-63. PubMed ID: 25377899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
    Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
    J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-operative intra-protein structural response due to protein-protein complexation revealed through thermodynamic quantification: study of MDM2-p53 binding.
    Samanta S; Mukherjee S
    J Comput Aided Mol Des; 2017 Oct; 31(10):891-903. PubMed ID: 28871352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding induced folding in p53-MDM2 complex.
    Chen HF; Luo R
    J Am Chem Soc; 2007 Mar; 129(10):2930-7. PubMed ID: 17302414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
    Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
    J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics.
    Pantelopulos GA; Mukherjee S; Voelz VA
    Proteins; 2015 Sep; 83(9):1665-76. PubMed ID: 26138282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
    Lemos A; Leão M; Soares J; Palmeira A; Pinto M; Saraiva L; Sousa ME
    Med Res Rev; 2016 Sep; 36(5):789-844. PubMed ID: 27302609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of MDM2 and MDMX: a structural perspective.
    Riedinger C; McDonnell JM
    Future Med Chem; 2009 Sep; 1(6):1075-94. PubMed ID: 21425995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the conformational transitions of MDM2 and MDMX: insights into key residues affecting p53 recognition.
    Carotti A; Macchiarulo A; Giacchè N; Pellicciari R
    Proteins; 2009 Nov; 77(3):524-35. PubMed ID: 19507240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.
    Pazgier M; Liu M; Zou G; Yuan W; Li C; Li C; Li J; Monbo J; Zella D; Tarasov SG; Lu W
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4665-70. PubMed ID: 19255450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2.
    Goyal S; Grover S; Dhanjal JK; Tyagi C; Goyal M; Grover A
    J Mol Graph Model; 2014 Jun; 51():64-72. PubMed ID: 24858256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.